Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2026-04-18 @ 2:53 PM
Study NCT ID:
NCT00270361
Status:
COMPLETED
Last Update Posted:
2011-07-26
First Post:
2005-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
Sponsor:
Scios, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR003316
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None